Market overview:

According to the research reports by MRFR, the global psoriasis treatment market Size is likely to cross a market size of over USD 13.1 billion in 2027 while recording a healthy CAGR of over 7.3% during the review timeframe.

Psoriasis is a chronic inflammatory skin condition that frequently links with our systematic manifestation. The global psoriasis treatment market has witnessed massive growth over recent years owing to the factors such as various developments of advanced technologies, the green prevalence of psoriasis, increasing awareness for the treatment, and the growing research and development for the treatment. However, the market's growth is likely to be hampered by the high costs involved in the treatment. Nevertheless, the growing occurrence of this disease across the globe is likely to offer lucrative opportunities over the assessment timeframe.

Segment Analysis

The global psoriasis treatment market is bifurcated into several segments based on treatment, drug class, and region.

Based on the drug class, the global market for psoriasis treatment is divided into vitamin D analogs, interleukin inhibitors, and tumor necrosis factor inhibitors.

The global psoriasis treatment market is split into biologics, systematic, and topical based on the treatment.

Regional Analysis

The global psoriasis treatment market is studied across five major regions, including the Middle East & Africa, North America, South America, Europe, and Asia-Pacific.

As per the MRFR research reports, the North American region is likely to secure the top position in the psoriasis treatment market due to the rising number of global market trends of psoriasis treatment. Furthermore, the growth of the regional market is being driven by an increasing prevalence of psoriasis, the presence of major manufacturers, and growing awareness growth among people. As per the recent survey, approximately 8 million Americans have psoriasis.

In 2018, the European region secured the second position in the psoriasis treatment market across the globe. The regional market will likely record the fastest growth rate over the assessment timeframe. The regional market's growth is attributed to the prominent market players, the growing participation of major market leaders, and the growing senior population.

The Middle East & African regional free psoriasis samples treatment will record the slowest growth rate over the review timeframe. This is because of less awareness among the people in Africa and the low economic developments across the region.

Competitive Analysis

The global market for psoriasis treatment has an intensely competitive landscape with a wide number of players spread worldwide. The players in the market are adopting several new strategies such as product developments, mergers, acquisitions, and partnerships to strengthen their global market footprint. The list of prominent players in the psoriasis treatment market includes names such as Eli Lilly and Company, AbbVie (US), Pfizer Inc (US), Celgene Corporation (US), UCB (Belgium), Amgen (US), Merck and Co. Inc (US), Johnson & Johnson (US), AstraZeneca (UK), Novartis International AG (Switzerland), and many others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com